4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-25-011872
EVP, CHIEF FINANCIAL OFFICER sold 3,498 shares at $14.60 ($51,071)
- EVP, CHIEF FINANCIAL OFFICER acquired 6,815 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-05-01 | Option exercise | +6,815 | 66,271 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-05-02 | Sale | −3,498 | $14.60 | $51,071 | 62,773 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-05-01 | Option exercise · Restricted Stock Units | −6,815 | 13,630 | D | ||
| Open-market sales · 3,498 sh · avg $14.60 · $51,071 | |||||||
Loading xslF345X05/form4-05022025_110505.xml…